Pharmaceutical Executive

Pharmaceutical Executive-10-15-2007
Volume: 0
Issue: 0

Pharmaceutical Executive-10-01-2007
Volume: 0
Issue: 0

Pharmaceutical Executive-10-01-2007
Volume: 0
Issue: 0
Pharmaceutical Executive-10-03-2007
Volume: 0
Issue: 0
Pharmaceutical Executive-09-06-2007
Volume: 0
Issue: 0
Pharmaceutical Executive-09-12-2007
Volume: 0
Issue: 0

Pharmaceutical Executive-09-01-2007
Volume: 0
Issue: 0

Pharmaceutical Executive-09-01-2007
Volume: 0
Issue: 0
Pharmaceutical Executive-09-19-2007
Volume: 0
Issue: 0
Pharmaceutical Executive-09-26-2007
Volume: 0
Issue: 0
Pharmaceutical Executive-08-01-2007
Volume: 0
Issue: 0
Pharmaceutical Executive-08-22-2007
Volume: 0
Issue: 0
Pharmaceutical Executive-08-29-2007
Volume: 0
Issue: 0
Pharmaceutical Executive-08-08-2007
Volume: 0
Issue: 0
Pharmaceutical Executive-08-15-2007
Volume: 0
Issue: 0

Pharmaceutical Executive-07-01-2007
Volume: 5
Issue: 5

Pharmaceutical Executive-07-30-2007
Volume: 0
Issue: 0
Pharmaceutical Executive-07-18-2007
Volume: 0
Issue: 0
Pharmaceutical Executive-07-25-2007
Volume: 0
Issue: 0
Pharmaceutical Executive-07-11-2007
Volume: 0
Issue: 0

Pharmaceutical Executive-07-03-2007
Volume: 0
Issue: 0
Pharmaceutical Executive-07-03-2007
Volume: 0
Issue: 0

Pharmaceutical Executive-06-01-2007
Volume: 0
Issue: 0
Pharmaceutical Executive-06-06-2007
Volume: 0
Issue: 0
Pharmaceutical Executive-06-13-2007
Volume: 0
Issue: 0

Pharmaceutical Executive-06-01-2007
Volume: 0
Issue: 0

Pharmaceutical Executive-06-18-2007
Volume: 0
Issue: 0
Pharmaceutical Executive-06-20-2007
Volume: 0
Issue: 0
Pharmaceutical Executive-06-27-2007
Volume: 0
Issue: 0

Pharmaceutical Executive-05-01-2007
Volume: 5
Issue: 3
Advertisement
Advertisement
Trending on PharmExec
1
Your Phase III Clinical Protocol Is Your Initial Product Launch
2
Pharmaceutical Executive Daily: Public Citizen Sues The Trump Administration Over Undisclosed Drug Price Agreements
3
Taking Advantage of ‘Hidden Gem’ Talent Hubs
4
AstraZeneca Enters $4.7 Billion Collaboration Agreement with CSPC Pharmaceuticals
5
